Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D.J. Pearson, Sara M. Federico, Susanne A. Gatz, Michael V. Ortiz, Giovanni Lesa, Nicole Scobie, Ioannis Gounaris, Susan Weiner, Brenda J. Weigel, TJ Unger, Elizabeth Stewart, Malcolm A. Smith, Emily K. Slotkin, Gregory H. Reaman, Alberto S. Pappo, Karsten Nysom, Koen Norga, Joe McDonough, Lynley V. Marshall, Donna Ludwinski, Franca Ligas, Dominik Karres, Marcel Kool, Thierry Horner, Anton G. Henssen, Delphine Heenen, Douglas S. Hawkins, Lia Gore, Julia Glade Bender, Sara Galluzzo, Elizabeth Fox, Teresa de Rojas, Barry R. Davies, Jayeta Chakrabarti, Juliet Carmichael, Diana Bradford, P. Blanc, Ronald J. Bernardi, Sylvie Benchetrit, Korede Akindele, Gilles Vassal
Topics & Concepts
MedicineClinical trialDrug developmentDNA repairOrphan drugCancerCancer researchDrugPharmacologyBioinformaticsBiologyDNAInternal medicineGeneticsPARP inhibition in cancer therapyCancer therapeutics and mechanismsDNA Repair Mechanisms